# US 2026/0158096 A1 · Methods and Formulations for Immuno-Rejuvenation to Prevent or Mitigate Inflammaging Through the Epigenetic Impact of a Polyphenol-Rich Agent Derived from Uniquely Applied Tartary Buckwheat

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0158096 A1
- Document ID: US20260158096A1
- Status: Published application
- Kind: A1
- Application number: 19/402,110
- Filed: 2025-11-26
- Published: 2026-06-11
- Earliest claimed: 2024-12-06
- Assignees: Big Bold Health
- Applicants: Big Bold Health
- Inventors: Jeffrey S. Bland; Austin Perlmutter
- Web page: https://patentgrep.com/patent/US20260158096A1

## CPC

- A61K 36/70: Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/555: containing heavy metals, e.g. hemin, hematin, melarsoprol
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K 2236/11: involving culturing conditions, e.g. cultivation in the dark or under defined water stress
- A61K 2236/15: involving mechanical treatment, e.g. chopping up, cutting or grinding
- A61K 2236/19: involving fermentation using yeast, bacteria or both; enzymatic treatment
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Development of producing certain methods of and nutrition management of Tartary buckwheat (Fagopyrum Tataricum) to promote immuno-rejuvenation by influencing key pathways involved in aging, inflammation and immune system function.

## Claims

### Claim 1

The process of inhibiting biologic aging in human or domesticated animal subject by certain administration steps of Tartary buckwheat utilizing enhanced amounts of polyphenol-rich agents administered in dosages effective for particular categories of subjects to elevate immune function through epigenetic alteration by steps of:
(a) creating an enhanced form of Tartary buckwheat by cold environment seed or root planting harvested at post germination sprouting stage and adding beneficial microorganisms at seeding and/or growth stages pre-sprouting guided by methylation patterns;
(b) micronization processing of the harvested material to powder, leaf capsules or liquid forms for ingestion in diet and/or blood system inoculation, the beneficial microorganisms being selected from the group consisting of symbiotic bacterial, mycorrhizal fungi, singly or in combinations, thereof;
(c) further adding at sprout stage or subsequently in dosing in diet and/or inoculation additives selected from the group of omega-3 fatty acids, probiotics, prebiotics, vitamins, minerals, fermented products or other nutraceuticals, singly and/or any combination;
(d) adjusting diet or inoculation of a subject in relation to one or more singly or any combination markers from the group consisting of a subject's genomic instability, telomere alteration, epigenetic alteration, loss of proteostasis, deregulated nutrient sensing, mitochondrial, dysfunction, cellular senescence, stem cell, exhaustion, altered intercellular communication;
(e) managing over a selected term of a group consisting of a program of such diet and/or inoculation effects and if indicated revising the program to measure improvement of immune function, biological aging through increased epigenetic alterations through a pattern of CpG alterations and/or inhibition of pro-inflammatory cytokines including IL-6, TNF-alpha or beneficial alterations in the immune system including positive changes to innate or adaptive immune cell makeup.

### Claim 2 (depends on 1)

The process of claim 1 wherein after seed planting and germination in cold stress drought conditions, the sprouting is done at a stage effective to produce content of rutin in the sprouted Tartary buckwheat of more than 100 times or more versus content of unsprouted buckwheat and quercetin content of 90 times or more versus content of unsprouted buckwheat and wherein the polyphenol content is 2 fold compared to unsprouted common buckwheat.

### Claim 3 (depends on 2)

The process of claim 2 wherein the harvesting is done 3 days after germination and the milling or other micronization step is done 4 days after initial sprouting.

### Claim 4 (depends on 3)

The process of claim 3 wherein fermentation is combined with micronization.

### Claim 5 (depends on 1)

The composition of processed Tartary buckwheat as produced by the process of claim 1.

### Claim 6 (depends on 5)

The process of feeding subjects the composition of claim 5 approximately/preferably at the amounts shown on Table 1 Formulation of the specification for a period of 12 to 24 weeks, without prejudice to benefits of feeding at lesser or greater time durations for subjects with population characteristics as shown on Table 2 of Formulation 1.

### Claim 7 (depends on 6)

The process of claim 6 adjusted to achieve by demethylation as indicated in FIGS. 1-3 and related specification text and ultimate results as shown on Tables 3 and 4.

### Claim 8 (depends on 1)

The process of reducing elderly age related immunosenescence and/or chronic inflammation and related disorders thorough dietary regular comprising use of dietary polyphenols uniquely abundant in Tartary buckwheat created, processed and adjusted as set forth in claim 1.
